There are concerns that Anthropic may be impacting Palantir's commercial contract prospects. The value of Palantir has reportedly taken a hit, with some critics, including a notable investor, expressing negative views on the company. The outlook for Palantir's stock is uncertain, with varying assessments of its value and potential.